We are studying how the medication baricitinib works in children aged 1 to under 18 years who are hospitalized with COVID-19. This research aims to ensure the safety and proper dosing for young patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2, leading to symptoms that can range from mild respiratory issues to severe illness. It spreads primarily through respiratory droplets when an infected person coughs, sneezes, or talks.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.